Featured

Johnson & Johnson dropped $14.6 billion on a company whose value rests almost entirely on one psychiatric drug. Caplyta may be a blockbuster, or it may be the most expensive overreach in biotech since 2022. This is a high-risk, high-premium gamble at a moment when Big Pharma can’t afford missteps.

One activist email can now do what used to take a full proxy war: topple a CEO. With record campaigns and the Universal Proxy Card turning every board seat into open combat, corporate governance has become faster, louder, and far more ruthless than ever before.

Alkermes just placed a $2.1 billion bet on sleep with a sleep drug few investors saw coming. Alkermes isn’t just buying Avadel, it’s buying time and maybe the future of mental health medicine.

Elon Musk just paid $17 billion for spectrum licenses, most experts call worthless, 100 times the going rate. On paper, the deal looks insane. Through Washington’s lens, it’s the smartest move SpaceX has ever made.

While everyone piles into AI stocks, the big banks are sandbagging earnings and loading their loan books for the windfall that comes when millions need credit to survive automation.

LVMH’s sharpest sales drop since 2008 is more than a fashion story. Luxury’s downturn has historically foreshadowed recessions, and today it coincides with weakening confidence, asset stress, and slowing global demand.

As Vice Chairman of the Financial Services Committee, Tim Moore helps set the rules for America’s markets. He is also betting millions that those markets, and the small businesses they support, are about to fail.

Michael Burry is betting on a rebound, Donald Trump is buying the bonds, and UnitedHealth sits at the center of a quiet wager that could redefine American healthcare.

A single $5 million ‘Gold Card’ could raise more in a year than EB-5 did in a decade—and that’s just Phase One. Pair it with a 15 % flat corporate tax, a $100 K talent fast-track, and $50 K fines for illegal hires, and America stops managing decline and starts monetizing its magnetism.

Three perfectly timed 75 K share blocks. $13 million pocketed before lunch. Add it to the $2 billion that Nvidia insiders have dumped since 2020, while retail investors continue to bid the stock to new highs.

Tesla just posted its sharpest quarterly revenue drop in more than a decade—12 % year-on-year—and warned of “rough quarters” ahead.

Beijing’s $586 billion export boom isn’t real demand—it’s a last-minute inventory grab before August-1 tariffs, priming factories for a post-surge deflation crash.

Johnson & Johnson dropped $14.6 billion on a company whose value rests almost entirely on one psychiatric drug. Caplyta may be a blockbuster, or it may be the most expensive overreach in biotech since 2022. This is a high-risk, high-premium gamble at a moment when Big Pharma can’t afford missteps.

Elon Musk just paid $17 billion for spectrum licenses, most experts call worthless, 100 times the going rate. On paper, the deal looks insane. Through Washington’s lens, it’s the smartest move SpaceX has ever made.

The United States has just converted a national security tool into a revenue stream, forcing Nvidia and AMD to surrender 15% of their China chip sales to Washington. What began as a semiconductor export control is now a blueprint for governments to claim stakes in private companies’ earnings.

Three perfectly timed 75 K share blocks. $13 million pocketed before lunch. Add it to the $2 billion that Nvidia insiders have dumped since 2020, while retail investors continue to bid the stock to new highs.

ChatGPT’s co-creator just shredded his OpenAI badge and walked straight into Zuckerberg’s $65 billion Super-intelligence Lab. This isn’t a hire—it’s a hostile takeover of brains.

Tesla just posted its sharpest quarterly revenue drop in more than a decade—12 % year-on-year—and warned of “rough quarters” ahead.

Shares of The Metals Company have rocketed 580 % on a single, audacious bet: that U.S. regulators will green-light the world’s first commercial raid on 4 000-metre-deep ‘battery rocks’ packed with nickel, cobalt and copper

Aimed at regulating stablecoins, GENIUS Act quietly builds a parallel dollar system that bypasses the Fed, marking the biggest transfer of monetary power from Washington to corporate boardrooms in U.S. history.

With 1.5 % of the Allied GDP now earmarked for “broader defense,” a torrent of cash is shifting from tanks to satellites, changing the entire industry for warfare that starts in space.

While everyone piles into AI stocks, the big banks are sandbagging earnings and loading their loan books for the windfall that comes when millions need credit to survive automation.

Tesla just posted its sharpest quarterly revenue drop in more than a decade—12 % year-on-year—and warned of “rough quarters” ahead.

Shares of The Metals Company have rocketed 580 % on a single, audacious bet: that U.S. regulators will green-light the world’s first commercial raid on 4 000-metre-deep ‘battery rocks’ packed with nickel, cobalt and copper

Aimed at regulating stablecoins, GENIUS Act quietly builds a parallel dollar system that bypasses the Fed, marking the biggest transfer of monetary power from Washington to corporate boardrooms in U.S. history.

Surging data-center demand is turning utilities like Talen into dedicated AI-infrastructure providers, redirecting billions from renewables to gas plants, making control of electricity the decisive lever of modern economy.

One activist email can now do what used to take a full proxy war: topple a CEO. With record campaigns and the Universal Proxy Card turning every board seat into open combat, corporate governance has become faster, louder, and far more ruthless than ever before.

As Vice Chairman of the Financial Services Committee, Tim Moore helps set the rules for America’s markets. He is also betting millions that those markets, and the small businesses they support, are about to fail.

Conflux’s move turns private crypto rails into Beijing’s sharpest tool yet for chipping away at U.S. payments supremacy

While everyone piles into AI stocks, the big banks are sandbagging earnings and loading their loan books for the windfall that comes when millions need credit to survive automation.

With six S&P sectors poised for profit declines and forward P/Es near 22×, this earnings season could be the pin that finally tests the market’s helium balloon.

Johnson & Johnson dropped $14.6 billion on a company whose value rests almost entirely on one psychiatric drug. Caplyta may be a blockbuster, or it may be the most expensive overreach in biotech since 2022. This is a high-risk, high-premium gamble at a moment when Big Pharma can’t afford missteps.

When a company with $5.3 billion in debt and a 47% stock collapse attracts a hedge fund and an NFL star, it’s not charity, it’s strategy. Jana Partners and Travis Kelce are betting they can turn Six Flags from a sinking relic into a comeback story worth watching.

Alkermes just placed a $2.1 billion bet on sleep with a sleep drug few investors saw coming. Alkermes isn’t just buying Avadel, it’s buying time and maybe the future of mental health medicine.

LVMH’s sharpest sales drop since 2008 is more than a fashion story. Luxury’s downturn has historically foreshadowed recessions, and today it coincides with weakening confidence, asset stress, and slowing global demand.

As Vice Chairman of the Financial Services Committee, Tim Moore helps set the rules for America’s markets. He is also betting millions that those markets, and the small businesses they support, are about to fail.

Johnson & Johnson dropped $14.6 billion on a company whose value rests almost entirely on one psychiatric drug. Caplyta may be a blockbuster, or it may be the most expensive overreach in biotech since 2022. This is a high-risk, high-premium gamble at a moment when Big Pharma can’t afford missteps.

Alkermes just placed a $2.1 billion bet on sleep with a sleep drug few investors saw coming. Alkermes isn’t just buying Avadel, it’s buying time and maybe the future of mental health medicine.

Michael Burry is betting on a rebound, Donald Trump is buying the bonds, and UnitedHealth sits at the center of a quiet wager that could redefine American healthcare.

One activist email can now do what used to take a full proxy war: topple a CEO. With record campaigns and the Universal Proxy Card turning every board seat into open combat, corporate governance has become faster, louder, and far more ruthless than ever before.

When a company with $5.3 billion in debt and a 47% stock collapse attracts a hedge fund and an NFL star, it’s not charity, it’s strategy. Jana Partners and Travis Kelce are betting they can turn Six Flags from a sinking relic into a comeback story worth watching.

Three perfectly timed 75 K share blocks. $13 million pocketed before lunch. Add it to the $2 billion that Nvidia insiders have dumped since 2020, while retail investors continue to bid the stock to new highs.

ChatGPT’s co-creator just shredded his OpenAI badge and walked straight into Zuckerberg’s $65 billion Super-intelligence Lab. This isn’t a hire—it’s a hostile takeover of brains.

One activist email can now do what used to take a full proxy war: topple a CEO. With record campaigns and the Universal Proxy Card turning every board seat into open combat, corporate governance has become faster, louder, and far more ruthless than ever before.

When a company with $5.3 billion in debt and a 47% stock collapse attracts a hedge fund and an NFL star, it’s not charity, it’s strategy. Jana Partners and Travis Kelce are betting they can turn Six Flags from a sinking relic into a comeback story worth watching.

A single $5 million ‘Gold Card’ could raise more in a year than EB-5 did in a decade—and that’s just Phase One. Pair it with a 15 % flat corporate tax, a $100 K talent fast-track, and $50 K fines for illegal hires, and America stops managing decline and starts monetizing its magnetism.

Elon Musk just paid $17 billion for spectrum licenses, most experts call worthless, 100 times the going rate. On paper, the deal looks insane. Through Washington’s lens, it’s the smartest move SpaceX has ever made.

A single $5 million ‘Gold Card’ could raise more in a year than EB-5 did in a decade—and that’s just Phase One. Pair it with a 15 % flat corporate tax, a $100 K talent fast-track, and $50 K fines for illegal hires, and America stops managing decline and starts monetizing its magnetism.

Shares of The Metals Company have rocketed 580 % on a single, audacious bet: that U.S. regulators will green-light the world’s first commercial raid on 4 000-metre-deep ‘battery rocks’ packed with nickel, cobalt and copper